Atlas Trials

Antiva Biosciences

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Antiva Biosciences

RecordFirmDate
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts (NCT06491446)Antiva Biosciences2024-03-27
A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia (NCT05502367)Antiva Biosciences2022-09-10
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. (NCT03697226)Antiva Biosciences2018-12-21
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03677960)Antiva Biosciences2018-12-17
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection (NCT03239223)Antiva Biosciences2018-01-01
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03202992)Antiva Biosciences2017-08-11

Track Antiva Biosciences automatically

Every clearance here is in the API, with alerts when new ones post.